LANZAFAME, Helena
 Distribuzione geografica
Continente #
EU - Europa 254
NA - Nord America 218
AS - Asia 25
Continente sconosciuto - Info sul continente non disponibili 1
Totale 498
Nazione #
US - Stati Uniti d'America 218
IE - Irlanda 79
SE - Svezia 68
IT - Italia 61
PL - Polonia 18
AT - Austria 8
CN - Cina 8
DE - Germania 8
BE - Belgio 7
IN - India 6
SG - Singapore 6
IR - Iran 2
VN - Vietnam 2
CZ - Repubblica Ceca 1
EU - Europa 1
FI - Finlandia 1
FR - Francia 1
GB - Regno Unito 1
HK - Hong Kong 1
MK - Macedonia 1
Totale 498
Città #
Chandler 90
Dublin 77
Nyköping 53
Messina 20
Warsaw 18
Princeton 15
Rome 11
Ashburn 10
Medford 10
Bremen 8
Des Moines 8
Vienna 8
Brussels 7
Hyderabad 5
New York 4
Torregrotta 4
Waverly Hall 4
Ann Arbor 3
Nanjing 3
Redwood City 3
Rometta Marea 3
Singapore 3
Augusta 2
Boardman 2
Dong Ket 2
Pozzo Di Gotto 2
Quinto Di Treviso 2
Santa Teresa Di Riva 2
Brno 1
Castelnuovo Rangone 1
Chengdu 1
Edinburgh 1
Hangzhou 1
Helsinki 1
Hong Kong 1
Houston 1
Jacksonville 1
Jinan 1
Leawood 1
Nanchang 1
Pescara 1
Zhengzhou 1
Totale 393
Nome #
PRRT Retreatments: Renal Function Evaluation 87
Peptide Receptor Radionuclide Therapy and Somatostatin 'cold' Analogues Therapy in the Treatment of GEP-NET Patients: Our Center’ Experience 70
Effectiveness, safety and haematological toxicity of 223Ra-Cl2: a single centre experience 63
BRAFV600Emutation is associated with increased prevalence of contralateral lymph-node metastases in low and low-to-intermediate risk papillary thyroid cancer 60
A Single Centre Experience with 223-Radium-Dichloride ((RaCl2)-Ra-223) Therapy 56
Early preablation rhTSH-stimulated thyroglobulin predicts outcome of differentiated thyroid cancer (DTC) patients 47
Prognostic Validity of Dual Tracer PET/CT In The PRRT Enrollment of GEP-NET Patients 45
BRAF and RAS mutations in differentiated thyroid cancer of patients with low-risk to intermediate-risk treated with radioiodine therapy 41
Artificial Intelligence Applications on Restaging [18F]FDG PET/CT in Metastatic Colorectal Cancer: A Preliminary Report of Morpho-Functional Radiomics Classification for Prediction of Disease Outcome 27
PSMA and Choline PET for the Assessment of Response to Therapy and Survival Outcomes in Prostate Cancer Patients: A Systematic Review from the Literature 27
Totale 523
Categoria #
all - tutte 2.898
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.898


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202014 0 0 0 0 0 0 0 0 0 0 0 14
2020/202171 11 2 17 2 8 4 4 6 5 4 5 3
2021/202292 2 4 2 8 4 3 1 3 2 9 9 45
2022/2023280 23 37 14 22 25 35 7 19 90 3 5 0
2023/202460 5 4 6 3 6 18 1 0 0 5 4 8
2024/20256 6 0 0 0 0 0 0 0 0 0 0 0
Totale 523